First Tracks Biotherapeutics filed an S-1, putting a San Diego pharma name in the IPO queue. No deal terms or size in the filing detail yet. New biotech issue supply is a decent read on risk appetite,
S-1 filing signals First Tracks Biotherapeutics' planned IPO registration with SEC.
What changed
S-1 filing signals First Tracks Biotherapeutics' planned IPO registration with SEC.
Why it matters
S-1 filing signals First Tracks Biotherapeutics' planned IPO registration with SEC. — impact context not separately stored; see What changed.
← Dashboard
Oct 26, 2026 02:01 PM ET